Ultrasonographic evaluation of post-COVID long-term lung changes and relation to prolonged COVID symptoms: a prospective cross-sectional study

Yıl 2024, Cilt: 10 Sayı: 5, 490 - 500, 04.09.2024

Nilgün Tan Tabakoğlu , Pervin Hancı Yılmaztürk , İlker Yılmam , Necdet Süt , Osman Nuri Hatipoğlu

https://doi.org/10.18621/eurj.1513218

Öz

Objectives: This study aims to evaluate lung findings using lung ultrasonography (USG) in patients with PCR-positive COVID-19 pneumonia treated in the ward or intensive care unit and to explore the relationship with prolonged COVID-19 symptoms.

Methods: This prospective cross-sectional study was conducted at the University Medical Faculty Hospital outpatient clinic from December 2022 to April 2023. It involved 54 adult patients with PCR-positive COVID-19 pneumonia, treated and discharged from the ward or intensive care unit (ICU). Clinical and demographic data, lung ultrasonography results, and prolonged COVID-19 symptoms were recorded.

Results: Among the 54 patients, the ICU group had a mean age of 52.84 ± 12.30 years, while the ward group had a mean age of 58.80 ± 11.36 years (P=0.085). Shortness of breath was the most common prolonged symptom in both groups. The ICU group had significantly more right lung B lines than the ward group (P=0.002). Myalgia was more frequent in the ward group (P=0.024). No significant differences were observed in other variables (P>0.05). Prolonged COVID-19 symptoms were interrelated (P<0.05), and the total number of B lines was significantly associated with dyspnea (P=0.023).

Conclusions: Our study demonstrated that lung USG is a valuable tool in the assessment of lung injury after COVID-19 and in the management of long-term COVID-19 symptoms. B lines detected by lung USG are significantly associated with the long-term COVID symptom of shortness of breath, and the number of B lines may be an important biomarker in the management of shortness of breath.

Anahtar Kelimeler

Lung ultrasonography, B lines, COVID-19, prolonged COVID, dyspnea

Etik Beyan

Ethics committee approval for this study was obtained from the Trakya University Faculty of Medicine Ethics Committee on 14/06/2021, with decision number:13/35 and protocol code: TUTF-BAEK-2021/292

Destekleyen Kurum

Trakya University Scientific Research Project

Proje Numarası

2022/131

Kaynakça

• 1. World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Available at: https://covid19.who.int/. Accessed September 17, 2023.
• 2. Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV; WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102-e107. doi: 10.1016/S1473-3099(21)00703-9.
• 3. Akar MN. Prolonged COVID. In: TOBB ETU Publications, 1st ed. Ankara, Ankara: TOBB ETÜ Publications; 2023: pp. 3-15.
• 4. Mahase E. Covid-19: What do we know about "long covid"? BMJ. 2020;370:m2815. doi: 10.1136/bmj.m2815.
• 5. Baris SA, Toprak OB, Cetinkaya PD, et al. The predictors of long-COVID in the cohort of Turkish Thoracic Society-TURCOVID multicenter registry: One year follow-up results. Asian Pac J Trop Med. 2022;15(9):400-409. doi: 10.4103/1995-7645.354422.
• 6. Rocca E, Zanza C, Longhitano Y, et al. Lung Ultrasound in Critical Care and Emergency Medicine: Clinical Review. Adv Respir Med. 2023;91(3):203-223. doi: 10.3390/arm91030017.
• 7. Walden A, Campbell A, Miller A, Wise M, eds. Ultrasound in the Critically Ill: A Practical Guide. 1st ed. Springer Nature; 2022: pp. 41-67. doi: 10.1007/978-3-030-71742-1.
• 8. Haaksma ME, Smit JM, Heldeweg MLA, Pisani L, Elbers P, Tuinman PR. Lung ultrasound and B-lines: B careful!. Intensive Care Med. 2020;46(3):544-545. doi: 10.1007/s00134-019-05911-8.
• 9. Xirouchaki N, Magkanas E, Vaporidi K, et al. Lung ultrasound in critically ill patients: comparison with bedside chest radiography. Intensive Care Med. 2011;37(9):1488-1493. doi: 10.1007/s00134-011-2317-y.
• 10. Volpicelli G, Elbarbary M, Blaivas M, et al. International Liaison Committee on Lung Ultrasound (ILC-LUS) for International Consensus Conference on Lung Ultrasound (ICC-LUS). International evidence-based recommendations for point-of-care lung ultrasound. Intensive Care Med. 2012;38(4):577-591. doi: 10.1007/s00134-012-2513-4.
• 11. Turkish Ministry of Health. e-Nabız Personal Health System. Available at: https://www.enabiz.gov.tr/. Accessed April 24, 2024.
• 12. Tabakoglu NT, Celik M. Evaluation of Health-Related Quality of Life in Patients with Euthyroid Hashimoto's Thyroiditis under Long-Term Levothyroxine Therapy: A Prospective Case-Control Study. J Clin Med. 2024;13(11):3082. doi: 10.3390/jcm13113082.
• 13. Ekström M, Sundh J, Andersson A, et al. Exertional breathlessness related to medical conditions in middle-aged people: the population-based SCAPIS study of more than 25,000 men and women. Respir Res. 2024;25(1):127. doi: 10.1186/s12931-024-02766-6.
• 14. Tabakoglu NT, Üstündağ S. Comparison of Prevalence and Severity of Depressive Symptoms in Hemodialysis Patients Before and During the COVID-19 Pandemic. Balkan Sağlık Bilimleri Dergisi. 2024;2(3):131-139. doi: 10.61830/balkansbd.1399034.
• 15. DePace NL, Colombo J. Long-COVID Syndrome and the Cardiovascular System: A Review of Neurocardiologic Effects on Multiple Systems. Curr Cardiol Rep. 2022;24(11):1711-1726. doi: 10.1007/s11886-022-01786-2.
• 16. Bilgin S, Yamanoğlu A, Kayalı A, et al. Long COVID symptoms among outpatients with COVID-19: a descriptive study. Cukurova Med J. 2023;48(1):243-252. doi: 10.17826/cumj.1216943.
• 17. Carfì A, Bernabei R, Landi F; Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324(6):603-605. doi: 10.1001/jama.2020.12603.
• 18. Fidan A, Cömert ŞŞ, Tokmak M, Saraç G, Salepçi B, Kıral N. [Retrospective analysis of aspiration pneumonia cases]. Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi. 2008;19(3):113-116. [Article in Turkish]
• 19. Grewal JS, Carlsten C, Johnston JC, Shah AS, Wong AW, Ryerson CJ. Post-COVID dyspnea: prevalence, predictors, and outcomes in a longitudinal, prospective cohort. BMC Pulm Med. 2023;23(1):84. doi: 10.1186/s12890-023-02376-w.
• 20. Garrigues E, Janvier P, Kherabi Y, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4-e6. doi: 10.1016/j.jinf.2020.08.029.
• 21. Iwakura K, Onishi T. A practical guide to the lung ultrasound for the assessment of congestive heart failure. J Echocardiogr. 2021;19(4):195-204. doi: 10.1007/s12574-021-00528-7.
• 22. Volpicelli G, Mussa A, Garofalo G, et al. Bedside lung ultrasound in the assessment of alveolar-interstitial syndrome. Am J Emerg Med. 2006;24(6):689-696. doi: 10.1016/j.ajem.2006.02.013.
• 23. Kimmig LM, Rako ZA, Ziegler S, et al. Long-term comprehensive cardiopulmonary phenotyping of COVID-19. Respir Res. 2022;23(1):263. doi: 10.1186/s12931-022-02173-9.
• 24. Scaramuzzo G, Ronzoni L, Campo G, et al. Long-term dyspnea, regional ventilation distribution and peripheral lung function in COVID-19 survivors: a 1 year follow up study. BMC Pulm Med. 2022;22(1):408. doi: 10.1186/s12890-022-02214-5.
• 25. Herndon CM, Nguyen V. Patterns of Viral Arthropathy and Myalgia Following COVID-19: A Cross-Sectional National Survey. J Pain Res. 2022;15:3069-3077. doi: 10.2147/JPR.S373295.
• 26. Ferrandi PJ, Alway SE, Mohamed JS. The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies. J Appl Physiol (1985). 2020;129(4):864-867. doi: 10.1152/japplphysiol.00321.2020.
• 27. Partridge LJ, Urwin L, Nicklin MJH, James DC, Green LR, Monk PN. ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin. Cells. 2021;10(6):1419. doi: 10.3390/cells10061419.
• 28. Sarkesh A, Sorkhabi AD, Sheykhsaran E, et al. Extrapulmonary Clinical Manifestations in COVID-19 Patients. Am J Trop Med Hyg. 2020;103(5):1783-1796. doi: 10.4269/ajtmh.20-0986.
• 29. Morley JE, Kalantar-Zadeh K, Anker SD. COVID-19: a major cause of cachexia and sarcopenia? J Cachexia Sarcopenia Muscle. 2020;11(4):863-865. doi: 10.1002/jcsm.12589.
• 30. Disser NP, De Micheli AJ, Schonk MM, et al. Musculoskeletal Consequences of COVID-19. J Bone Joint Surg Am. 2020;102(14):1197-1204. doi: 10.2106/JBJS.20.00847.
• 31. Nakanishi N, Liu K, Kawakami D, et al. Post-Intensive Care Syndrome and Its New Challenges in Coronavirus Disease 2019 (COVID-19) Pandemic: A Review of Recent Advances and Perspectives. J Clin Med. 2021;10(17):3870. doi: 10.3390/jcm10173870.
• 32. Smith EM, Lee ACW, Smith JM, Thiele A, Zeleznik H, Ohtake PJ. COVID-19 and post-intensive care syndrome: community-based care for ICU survivors. Home Health Care Manag Pract. 2021;33(2):117-124. doi: 10.1177/1084822320974956.
• 33. Fakili F, Cetinkaya PD, Baydar O. Post-discharge mortality in the first wave of COVID-19 in Turkey. Asian Pac J Trop Med. 2022;15(11):479-484. doi: 10.4103/1995-7645.361853.
• 34. Karacaer C, Karabay O, Gunduz Y, Yaylacı S, Guclu E. Correlation of Lung Ultrasound and Computed Tomography Findings in COVID-19 Pneumonia. J Coll Physicians Surg Pak. 2020;30(10):147-152. doi: 10.29271/jcpsp.2020.supp2.S147.
• 35. Soldati G, Smargiassi A, Inchingolo R, et al. Is There a Role for Lung Ultrasound During the COVID-19 Pandemic? J Ultrasound Med. 2020;39(7):1459-1462. doi: 10.1002/jum.15284.
• 36. Sofia S, Boccatonda A, Montanari M, et al. Thoracic ultrasound and SARS-COVID-19: a pictorial essay. J Ultrasound. 2020;23(2):217-221. doi: 10.1007/s40477-020-00458-7.
• 37. Smith MJ, Hayward SA, Innes SM, Miller ASC. Point-of-care lung ultrasound in patients with COVID-19 - a narrative review. Anaesthesia. 2020;75(8):1096-1104. doi: 10.1111/anae.15082.
• 38. Convissar DL, Gibson LE, Berra L, Bittner EA, Chang MG. Application of Lung Ultrasound During the COVID-19 Pandemic: A Narrative Review. Anesth Analg. 2020;131(2):345-350. doi: 10.1213/ANE.0000000000004929.